Mesoporous NaYbF4@NaGdF4 core-shell up-conversion nanoparticles for targeted drug delivery and multimodal imaging

Biomaterials

Volumn 35, Issue 26, 2014, Pages 7666-7678

  Zhou, Liangjun ^a,c   Zheng, Xiaopeng ^a,c   Gu, Zhanjun ^a   Yin, Wenyan ^a   Zhang, Xiao ^a   Ruan, Longfei ^a   Yang, Yanbo ^a   Hu, Zhongbo ^c   Zhao, Yuliang ^a,b  

^a INSTITUTE OF HIGH ENERGY PHYSICS   (China)

^b NATIONAL CENTER FOR NANOSCIENCE AND TECHNOLOGY   (China)

^c UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

Author keywords

Core shell; Mesoporous; Multimodality biomedical imaging; Targeted drug delivery; Up conversion nanoparticles

Indexed keywords

COMPUTERIZED TOMOGRAPHY; DRUG DELIVERY; LUMINESCENCE OF INORGANIC SOLIDS; MAGNETIC RESONANCE; MEDICAL IMAGING; MESOPOROUS MATERIALS; NANOPARTICLES;

BIOMEDICAL IMAGING; CORE-SHELL; MESOPOROUS; TARGETED DRUG DELIVERY; UP-CONVERSION;

SHELLS (STRUCTURES);

DOXORUBICIN; DRUG CARRIER; ERBIUM; FOLATE RECEPTOR; FOLIC ACID; GADOLINIUM; NANOPARTICLE; NANOSHELL; POLYETHYLENEIMINE; UNCLASSIFIED DRUG; UP CONVERSION NANOPARTICLE; YTTERBIUM; ANTINEOPLASTIC AGENT; CONTRAST MEDIUM; FLUORIDE; LUMINESCENT AGENT; SODIUM YTTRIUMTETRAFLUORIDE; YTTRIUM;

ARTICLE; CANCER CELL; CELL VIABILITY ASSAY; COMPUTER ASSISTED TOMOGRAPHY; DRUG DELIVERY SYSTEM; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LUMINESCENCE; MULTIMODAL IMAGING; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; SIGNAL NOISE RATIO; X RAY; ANIMAL; CELL LINE; CHEMICAL STRUCTURE; CHEMISTRY; DIAGNOSTIC USE; FEMALE; MOUSE; NEOPLASMS; NUCLEAR MAGNETIC RESONANCE IMAGING; PROCEDURES; TUMOR CELL LINE;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE; CELL LINE, TUMOR; CONTRAST MEDIA; DOXORUBICIN; DRUG DELIVERY SYSTEMS; FEMALE; FLUORIDES; FOLIC ACID; GADOLINIUM; HUMANS; LUMINESCENT AGENTS; MAGNETIC RESONANCE IMAGING; MICE; MODELS, MOLECULAR; MULTIMODAL IMAGING; NANOPARTICLES; NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED; YTTRIUM;

EID: 84902533705     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2014.05.051     Document Type: Article

References (58)

1. Li Z., Zhang Y., Jiang S. Multicolor core/shell-structured upconversion fluorescent nanoparticles. Adv Mater 2008, 20:4765-4769.
2. Gorris H.H., Wolfbeis O.S. Photon-upconverting nanoparticles for optical encoding and multiplexing of cells, biomolecules, and microspheres. Angew Chem Int Ed 2013, 52:3584-3600.
3. 4:Yb,Er nanoparticle-based dual-modal molecular probes for imaging tiny tumors invivo. ACS Nano 2013, 7:7227-7240.
4. Mai H.-X., Zhang Y.-W., Si R., Yan Z.-G., L-d Sun, You L.-P., et al. High-quality sodium rare-earth fluoride nanocrystals: controlled synthesis and optical properties. JAm Chem Soc 2006, 128:6426-6436.
5. Wang F., Han Y., Lim C.S., Lu Y., Wang J., Xu J., et al. Simultaneous phase and size control of upconversion nanocrystals through lanthanide doping. Nature 2010, 463:1061-1065.
6. Gai S., Li C., Yang P., Lin J. Recent progress in rare earth micro/nanocrystals: soft chemical synthesis, luminescent properties, and biomedical applications. Chem Rev 2014, 114:2343-2389.
7. 4 core/shell nanoparticles: excitation power density and surface dependence. JPhys Chem C 2009, 113:7164-7169.
8. Zhu H., Chen X., Jin L.M., Wang Q.J., Wang F., Yu S.F. Amplified spontaneous emission and lasing from lanthanide-doped up-conversion nanocrystals. ACS Nano 2013, 7:11420-11426.
9. Li C., Lin J. Rare earth fluoride nano-/microcrystals: synthesis, surface modification and application. JMater Chem 2010, 20:6831-6847.
10. 2 core/shell nanoparticles with efficient near-infrared to near-infrared upconversion for high-contrast deep tissue bioimaging. ACS Nano 2012, 6:8280-8287.
11. Zhang C., Lee J.Y. Prevalence of anisotropic shell growth in rare earth core-shell upconversion nanocrystals. ACS Nano 2013, 7:4393-4402.
12. 4 core/shell upconversion nanoparticles for bioimaging and drug delivery. RSC Adv 2012, 2:7037-7041.
13. Zhang F., Che R., Li X., Yao C., Yang J., Shen D., et al. Direct imaging the upconversion nanocrystal core/shell structure at the subnanometer level: shell thickness dependence in upconverting optical properties. Nano Lett 2012, 12:2852-2858.
14. Su Q., Han S., Xie X., Zhu H., Chen H., Chen C.-K., et al. The effect of surface coating on energy migration-mediated upconversion. JAm Chem Soc 2012, 134:20849-20857.
15. Jin S., Zhou L., Gu Z., Tian G., Yan L., Ren W., et al. Anew near infrared photosensitizing nanoplatform containing blue-emitting up-conversion nanoparticles and hypocrellin a for photodynamic therapy of cancer cells. Nanoscale 2013, 5:11910-11918.
16. Chien Y.-H., Chou Y.-L., Wang S.-W., Hung S.-T., Liau M.-C., Chao Y.-J., et al. Near-infrared light photocontrolled targeting, bioimaging, and chemotherapy with caged upconversion nanoparticles invitro and invivo. ACS Nano 2013, 7:8516-8528.
17. 3+ nanospheres for cell imaging and targeted anti-cancer drug delivery. Biomaterials 2013, 34:1601-1612.
18. 4-based upconversion nanophosphors for trimodality imaging of NIR-to-NIR upconversion luminescence, X-ray computed tomography and magnetic resonance. Biomaterials 2012, 33:5394-5405.
19. Xing H., Bu W., Zhang S., Zheng X., Li M., Chen F., et al. Multifunctional nanoprobes for upconversion fluorescence, MR and CT trimodal imaging. Biomaterials 2012, 33:1079-1089.
20. 2+ doping. Adv Funct Mater 2014, 10.1002/adfm.201304270.
21. 5:Yb/Er nanoprobes for multi-modal upconversion fluorescent, invivo X-ray computed tomography and biomagnetic imaging. Biomaterials 2012, 33:9232-9238.
22. 4:Gd/Yb/Er nanorods for blood vessel visualization. Biomaterials 2014, 35:2934-2941.
23. Jiang S., Zhang Y., Lim K.M., Sim E.K.W., Ye L. NIR-to-visible upconversion nanoparticles for fluorescent labeling and targeted delivery of siRNA. Nanotechnology 2009, 20:155101.
24. Wang C., Xu H., Liang C., Liu Y., Li Z., Yang G., et al. Iron oxide @ polypyrrole nanoparticles as a multifunctional drug carrier for remotely controlled cancer therapy with synergistic antitumor effect. ACS Nano 2013, 7:6782-6795.
25. Wang F., Banerjee D., Liu Y., Chen X., Liu X. Upconversion nanoparticles in biological labeling, imaging, and therapy. Analyst 2010, 135:1839-1854.
26. Dai Y., Xiao H., Liu J., Yuan Q., Pa Ma, Yang D., et al. Invivo multimodality imaging and cancer therapy by near-infrared light-triggered trans-platinum pro-drug-conjugated upconverison nanoparticles. JAm Chem Soc 2013, 135:18920-18929.
27. Yang Y., Velmurugan B., Liu X., Xing B. NIR photoresponsive crosslinked upconverting nanocarriers toward selective intracellular drug release. Small 2013, 9:2937-2944.
28. 3+@silica fiber nanocomposite. Adv Funct Mater 2011, 21:2356-2365.
29. Zhang X., Yang P., Dai Y., Pa Ma, Li X., Cheng Z., et al. Multifunctional up-converting nanocomposites with smart polymer brushes gated mesopores for cell imaging and thermo/pH dual-responsive drug controlled release. Adv Funct Mater 2013, 23:4067-4078.
30. Yang J., Deng Y., Wu Q., Zhou J., Bao H., Li Q., et al. Mesoporous silica encapsulating upconversion luminescence rare-earth fluoride nanorods for secondary excitation. Langmuir 2010, 26:8850-8856.
31. Yoo H.S., Park T.G. Folate-receptor-targeted delivery of doxorubicin nano-aggregates stabilized by doxorubicin-PEG-folate conjugate. JControl Release 2004, 100:247-256.
32. 2 hollow mesoporous spheres for targeted anticancer drug delivery. JPhys Chem C 2010, 114:16382-16388.
33. Fan N.C., Cheng F.Y., Ho J.A., Yeh C.S. Photocontrolled targeted drug delivery: photocaged biologically active folic acid as a light-responsive tumor-targeting molecule. Angew Chem Int Ed 2012, 51:8806-8810.
34. Setua S., Menon D., Asok A., Nair S., Koyakutty M. Folate receptor targeted, rare-earth oxide nanocrystals for bi-modal fluorescence and magnetic imaging of cancer cells. Biomaterials 2010, 31:714-729.
35. 4 upconversion nanophosphors with tunable emissions and their applications for biomedical imaging. JMater Chem 2012, 22:6974-6981.
36. 3 nanoparticles and their applications for optical and magnetic resonance imaging. JMater Chem 2012, 22:966-974.
37. 4 nanorods with dual-modal bio-optical and magnetic resonance imaging properties. Nanoscale 2012, 4:3754-3760.
38. + doping and their application for bioimaging. Chem Eur J 2012, 18:9239-9245.
39. Lusic H., Grinstaff M.W. X-ray-computed tomography contrast agents. Chem Rev 2012, 113:1641-1666.
40. Park J., An K., Hwang Y., Park J.G., Noh H.J., Kim J.Y., et al. Ultra-large-scale syntheses of monodisperse nanocrystals. Nat Mater 2004, 3:891-895.
41. Roberts J.E. Lanthanum and neodymium salts of trifluoroacetic acid. JAm Chem Soc 1961, 83:1087-1088.
42. 3+ upconverting nanoparticles synthesized by a one-pot solvothermal process. Nanoscale 2013, 5:3465-3473.
43. Basuki J.S., Duong H.T., Macmillan A., Erlich R.B., Esser L., Akerfeldt M.C., et al. Using fluorescence lifetime imaging microscopy to monitor theranostic nanoparticle uptake and intracellular doxorubicin release. ACS Nano 2013, 7:10175-10189.
44. Chang Y., Liu N., Chen L., Meng X., Liu Y., Li Y., et al. Synthesis and characterization of DOX-conjugated dendrimer-modified magnetic iron oxide conjugates for magnetic resonance imaging, targeting, and drug delivery. JMater Chem 2012, 22:9594.
45. Lee N., Choi S.H., Hyeon T. Nano-sized CT contrast agents. Adv Mater 2013, 25:2641-2660.
46. He Q., Ma M., Wei C., Shi J. Mesoporous carbon@silicon-silica nanotheranostics for synchronous delivery of insoluble drugs and luminescence imaging. Biomaterials 2012, 33:4392-4402.
47. Li C., Yang D., Pa Ma, Chen Y., Wu Y., Hou Z., et al. Multifunctional upconversion mesoporous silica nanostructures for dual modal imaging and invivo drug delivery. Small 2013, 9:4150-4159.
48. Chen Z., Chen H., Hu H., Yu M., Li F., Zhang Q., et al. Versatile synthesis strategy for carboxylic acid-functionalized upconverting nanophosphors as biological labels. JAm Chem Soc 2008, 130:3023-3029.
49. Ocaña M., Rodriguez-Clemente R., Serna C.J. Uniform colloidal particles in solution: formation mechanisms. Adv Mater 1995, 7:212-216.
50. Peng Q., Dong Y., Li Y. ZnSe semiconductor hollow microspheres. Angew Chem Int Ed 2003, 42:3027-3030.
51. Jiang Z.Y., Xie Z.X., Zhang X.H., Lin S.C., Xu T., Xie S.Y., et al. Synthesis of single-crystalline ZnO polyhedral submicrometer-sized hollow beads using laser-assisted growth with ethanol droplets as soft templates. Adv Mater 2004, 16:904-907.
52. Peruffo M., Mbogoro M.M., Edwards M.A., Unwin P.R. Holistic approach to dissolution kinetics: linking direction-specific microscopic fluxes, local mass transport effects and global macroscopic rates from gypsum etch pit analysis. Phys Chem Chem Phys 2013, 15:1956-1965.
53. Hulett G.A. The solubility of gypsum as affected by size of particles and by different crystallographic surfaces. JAm Chem Soc 1905, 27:49-56.
54. Wang C., Cheng L., Liu Z. Drug delivery with upconversion nanoparticles for multi-functional targeted cancer cell imaging and therapy. Biomaterials 2011, 32:1110-1120.
55. Guo M., Que C., Wang C., Liu X., Yan H., Liu K. Multifunctional superparamagnetic nanocarriers with folate-mediated and pH-responsive targeting properties for anticancer drug delivery. Biomaterials 2011, 32:185-194.
56. Di W., Ren X., Zhao H., Shirahata N., Sakka Y., Qin W. Single-phased luminescent mesoporous nanoparticles for simultaneous cell imaging and anticancer drug delivery. Biomaterials 2011, 32:7226-7233.
57. Liu Y., Ai K., Lu L. Nanoparticulate X-ray computed tomography contrast agents: from design validation to invivo applications. Acc Chem Res 2012, 45:1817-1827.
58. 3 up-conversion nanoparticle as an invivo X-ray CT imaging contrast agent. Biomaterials 2012, 33:6748-6757.